OBJECTIVES We tested the hypothesis that intramyocardial injection of autologous bone
marrow (ABM) promotes collateral development in ischemic porcine myocardium. We also …

Importance Neurofibrillary tangles composed of aggregated tau protein are one of the
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease …

Introduction Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD)
process yields conflicting results. The objective of the study was to assess plasma levels of …

Objectives To assess and compare cortical thickness (CTh) of patients with prodromal
Dementia with Lewy bodies (pro-DLB), prodromal Alzheimer's disease (pro-AD), DLB …

Importance Plasma phosphorylated tau (p-tau) has proven to be an accurate biomarker for
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …

OBJECTIVES To test the feasibility of myocardial angiogenic gene expression using a novel
catheter-based transendocardial injection system. BACKGROUND Angiogenesis has been …

Diffuse atrophy including the insula was previously demonstrated in dementia with Lewy
bodies (DLB) patients but little is known about the prodromal stage of DLB (pro-DLB). In this …

Background Fluctuations are one of the core clinical features characterizing dementia with
Lewy bodies (DLB). They represent a determining factor for its diagnosis and strongly impact …

Background Differential diagnosis between dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …

Background Several studies have investigated the value of alpha-synuclein assay in the
cerebrospinal fluid (CSF) of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) …